0001415889-17-000845.txt : 20170523
0001415889-17-000845.hdr.sgml : 20170523
20170523201109
ACCESSION NUMBER: 0001415889-17-000845
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170519
FILED AS OF DATE: 20170523
DATE AS OF CHANGE: 20170523
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: MABVAX THERAPEUTICS HOLDINGS, INC.
CENTRAL INDEX KEY: 0001109196
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 930987903
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 11535 SORRENTO VALLEY ROAD
STREET 2: SUITE 400
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 8582599405
MAIL ADDRESS:
STREET 1: 11535 SORRENTO VALLEY ROAD
STREET 2: SUITE 400
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
FORMER COMPANY:
FORMER CONFORMED NAME: TELIK INC
DATE OF NAME CHANGE: 20000313
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Varvaro Thomas C
CENTRAL INDEX KEY: 0001437495
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37861
FILM NUMBER: 17865284
MAIL ADDRESS:
STREET 1: 10005 MUIRLANDS BOULEVARD
STREET 2: SUITE G FIRST FLOOR
CITY: IRVINE
STATE: CA
ZIP: 95618
4
1
form4-05232017_050559.xml
X0306
4
2017-05-19
0001109196
MABVAX THERAPEUTICS HOLDINGS, INC.
MBVX
0001437495
Varvaro Thomas C
11535 SORRENTO VALLEY RD., SUITE 400
SAN DIEGO
CA
92121
true
false
false
false
Option to Purchase Common Stock
1.80
2017-05-19
4
A
0
50000
1.80
A
2027-05-19
Common Stock
50000
50000
D
The option is fully vested and exercisable and was issued pursuant to conditions of the Letter Agreement, dated May 15, 2017, by and between the Company and the lead investor in connection with the Company's public offering completed on May 19, 2017, and filed with the Securities and Exchange Commission on May 22, 2017 as Exhibit A of Exhibit 10.2 of the Company's Quarterly Report on Form 10-Q.
/s/ Jeremy D. Glaser , Attorney-in-Fact
2017-05-23